Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Yoko Bian
ID:
1b83acd4-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
39 articles
Sandoz & Polpharma Announce FDA and EMA Acceptance of Applications for Natalizumab Biosimilar
Big Molecule Watch ·
July 29, 2022
cite
Alvotech, a Global Pureplay Biosimilars Company, Debuted on Nasdaq Under the Ticker ALVO Today
Big Molecule Watch ·
June 16, 2022
cite
Organon and Henlius Entered into a Global License Agreement for Henlius’s PERJETA® (Pertuzumab) and PROLIA®/XGEVA® (Denosumab)
Big Molecule Watch ·
June 14, 2022
cite
Henlius and Eurofarma Entered into a License Agreement for Henlius’ 3 Products in Latin America
Big Molecule Watch ·
May 12, 2022
cite
Previous
1
...
7
8
Next